glycyrrhizin
role
immun
regul
central
nervou
system
impact
sciatic
nerv
injuri
previous
report
studi
balbc
mous
model
sciatic
nerv
injuri
use
explor
role
glycyrrhizin
sciatic
nerv
repair
underli
mechan
glycyrrhizin
intragastr
gavag
mgkg
weight
per
day
midand
highdos
respect
inhibit
neurotrophin
receptor
express
protein
mrna
level
versu
mgkg
lowdos
group
control
nacl
solut
one
two
four
eight
week
follow
sciatic
nerv
injuri
simultan
improv
action
potenti
amplitud
motor
nerv
conduct
veloc
combin
marsland
glee
erikson
silver
stain
luxol
fast
blue
stain
result
indic
highand
middos
glycyrrhizin
promot
improv
sciatic
nerv
myelin
compar
lowdos
control
group
eight
week
injuri
immunofluoresc
stain
demonstr
glycyrrhizin
inhibitori
effect
certain
degre
local
hypertroph
scar
inflammatori
respons
mous
model
conclus
glycyrrhizin
promot
sciatic
nerv
regener
function
repair
dose
mgkg
per
day
effect
lower
dose
regener
associ
downregul
glycyrrhizin
natur
occur
licoric
flavonoid
glycosid
extract
licoric
glycyrrhiza
uralensi
fisch
root
report
multipl
function
scaveng
free
radic
antibacteri
antiinflammatori
antivir
antiulc
effect
protect
cytochrom
enzym
antioxid
studi
shown
glycyrrhizin
regul
secret
variou
cytokin
function
immunomodulatori
effect
central
nervou
system
glycyrrhizin
also
improv
intracerebr
ischem
injuri
year
antiinflammatori
applic
treatment
liver
diseas
glycyrrhizin
gener
toxic
sideeffect
howev
effect
glycyrrhizin
function
recoveri
follow
peripher
nerv
injuri
well
understood
neurotrophin
receptor
one
nerv
signal
protein
play
signific
role
neuron
surviv
apoptosi
axon
growth
peripher
central
nervou
system
apoptosisinduc
receptor
demonstr
induc
cell
death
develop
peripher
sympathet
neuron
earli
retin
neuron
et
al
found
also
associ
inflammatori
respons
autoimmun
encephalomyel
mice
present
studi
explor
repar
effect
glycyrrhizin
sciatic
nerv
injuri
immun
inflammatori
respons
balbc
mous
model
reagent
anim
glycyrrhizin
iupac
name
acid
ca
number
molecular
formula
c
h
molecular
weight
da
puriti
purchas
xian
tianxingjian
natur
bioproduct
group
xian
shaanxi
china
structur
shown
fig
model
treatment
sciatic
nerv
injuri
model
creat
previous
describ
certain
modif
briefli
mice
underw
intraperiton
inject
ketamin
use
mgkg
weight
anesthesia
two
cmlongitudin
incis
asept
made
unilater
rear
thigh
sciatic
nerv
cord
complet
interrupt
cm
ischial
tuberos
immedi
underw
microsurg
anastomosi
use
microsutur
microsutur
angiotech
pharmaceut
inc
vancouv
bc
canada
final
muscl
skin
sutur
mice
random
four
group
mice
treat
differ
concentr
glycyrrhizin
four
differ
time
period
glycyrrhizin
dissolv
nacl
solut
administ
intragastr
daili
continu
day
final
high
midand
lowdos
gkg
weightday
respect
nacl
solut
equival
volum
serv
control
mice
sacrif
one
two
four
eight
week
injuri
electroneurophysiolog
test
affect
sciatic
nerv
underw
electroneurophysiolog
test
use
electromyograph
evok
potenti
machin
keypoint
medtron
ac
inc
skovlund
denmark
prior
mice
sacrif
previous
describ
certain
modif
briefli
sciatic
nerv
expos
pin
electrod
pierc
musculi
soleu
wave
record
point
ground
electrod
place
tail
singl
current
stimulu
employ
stimul
proxim
anastomot
ischial
tuberos
p
point
distal
sciatic
nerv
bifurc
point
point
respect
use
parallel
stimul
electrod
fix
space
mm
two
tip
motor
nerv
conduct
veloc
mncv
equal
distanc
p
point
divid
differ
valu
potenti
latenc
prepar
spinal
cord
specimen
affect
spinal
cord
segment
connect
injur
sciatic
nerv
dissect
dissoci
remov
previous
describ
tissu
store
liquid
nitrogen
use
quantit
polymeras
chain
reaction
qpcr
western
blot
analysi
altern
tissu
soak
neutral
buffer
formalin
fixat
h
dehydr
gradient
alcohol
embed
paraffin
use
western
blot
qpcr
analysi
western
blot
procedur
routin
perform
previous
describ
goat
antirat
polyclon
antibodi
santa
cruz
biotechnolog
inc
dalla
tx
usa
dilut
time
phosphatebuff
salin
contain
bovin
serum
albumin
beyotim
inc
nanj
china
qpcr
experi
total
rna
extract
tissu
use
trizol
invitrogen
carlsbad
ca
usa
reagent
method
cdna
synthes
revers
transcript
use
total
rna
templat
mrna
detect
qpcr
use
cdna
templat
reduc
glyceraldehydephosph
dehydrogenas
gapdh
serv
housekeep
gene
reaction
system
rel
mrna
level
determin
reaction
condi
tion
cycl
sec
sec
sec
gapdh
primer
design
base
ncbi
genbank
sequenc
use
beacon
design
softwar
premier
biosoft
inc
palo
alto
ca
usa
synthes
sangon
bioengin
inc
shanghai
china
primer
sequenc
sens
antisens
probe
gapdh
primer
sequenc
sens
antisens
probe
histolog
examin
paraffinembed
tissu
section
transvers
slice
thick
slice
stain
use
combin
marsland
glee
erikson
silver
stain
marsland
luxol
fast
blue
lfb
stain
method
previous
describ
nerv
fiber
stain
black
myelin
stain
blue
slice
five
microscop
field
magnif
randomli
select
imag
captur
diamet
number
myelin
fiber
calcul
use
imag
analysi
softwar
imagepro
plu
media
cybernet
inc
silver
spring
md
usa
immunofluoresc
stain
paraffinembed
tissu
section
slice
thick
indirect
immunofluoresc
stain
routin
perform
detect
express
astrocyt
glial
fibrillari
acid
protein
gfap
stain
blue
neuronspecif
enolas
nse
stain
green
goat
antirat
gfap
nse
monoclon
antibodi
santa
cruz
biotechnolog
inc
dilut
time
fluoresc
intens
five
random
field
measur
use
confoc
laser
scan
microscop
olympu
inc
beij
china
excit
wavelength
nm
nm
blue
green
fluoresc
respect
statist
analysi
data
present
mean
standard
deviat
spss
statist
packag
spss
inc
chicago
il
usa
use
statist
analysi
student
ttest
use
comparison
group
p
use
indic
statist
signific
differ
electrophysiolog
test
function
recoveri
sciatic
nerv
determin
action
potenti
amplitud
mncv
tabl
amplitud
mncv
highand
middos
group
one
two
four
eight
week
injuri
significantli
higher
lowdos
control
group
p
statist
signific
differ
highand
middos
group
lowdos
control
group
administr
glycyrrhizin
mgkgday
acceler
function
recoveri
injur
sciatic
nerv
mice
western
blot
qpcr
analysi
western
blot
analysi
result
shown
fig
blot
grayscal
ratio
tabl
ii
level
protein
group
increas
markedli
one
two
week
injuri
decreas
markedli
two
eight
week
timepoint
glycyrrhizin
treatment
group
significantli
reduc
protein
express
versu
control
group
p
meanwhil
highand
middos
group
one
four
week
show
lower
level
protein
versu
lowdos
group
p
highdos
group
express
significantli
reduc
level
versu
lowdos
group
two
week
p
qpcr
analysi
result
shown
fig
overal
level
mrna
group
increas
follow
injuri
decreas
level
mrna
lowdos
control
group
increas
one
four
week
decreas
four
eight
week
decreas
mrna
express
highand
middos
group
occur
earli
two
eight
week
mrna
express
highand
middos
group
significantli
lower
versu
control
p
timepoint
applic
glycyrrhizin
particularli
use
dose
mg
kgday
markedli
inhibit
express
protein
mrna
level
tabl
neuroelectrophysiolog
potenti
amplitud
mv
mncv
msec
dose
group
timepoint
follow
injuri
histolog
stain
nerv
fiber
myelin
dualli
stain
use
combin
marsland
lfb
stain
method
detect
nerv
regener
myelin
eight
week
injuri
nerv
fiber
stain
black
myelin
stain
blue
fig
myelin
sheath
high
fig
middos
group
fig
regularli
shape
uniform
thick
possess
clear
border
littl
fibrou
hyperplasia
myelin
sheath
lowdos
group
irregular
shape
thick
possess
clear
border
visibl
fibrou
hyperplasia
fig
myelin
sheath
control
group
extrem
irregularli
shape
mark
fibrou
hyperplasia
fig
base
dual
stain
imag
number
myelin
fiber
five
random
microscop
field
averag
diamet
analyz
use
imag
analysi
softwar
imagepro
plu
tabl
iii
number
diamet
myelin
fiber
highand
middos
group
timepoint
significantli
higher
lowdos
control
group
respect
p
statist
signific
differ
highand
middos
group
lowdos
control
group
use
mgkg
dose
glycyrrhizin
per
day
acceler
nerv
regener
immunofluoresc
stain
express
gfap
nse
astrocyt
detect
indirect
immunofluoresc
stain
eight
week
injuri
gfap
stain
appear
blue
dot
nse
stain
appear
abund
green
cytoplasm
fig
overal
gfap
nse
express
four
group
highdos
group
fig
less
express
gfap
indic
fewer
blue
dot
express
nse
indic
green
dot
cytoplasm
middos
fig
lowdos
fig
group
middos
lowdos
group
less
express
gfap
nse
cytoplasm
control
fig
control
group
certain
specimen
observ
form
glial
scar
fluoresc
densiti
group
shown
tabl
iii
glycyrrhizin
treatment
group
less
blue
fluoresc
green
fluoresc
control
p
highdos
group
less
blue
fluoresc
green
fluoresc
lowdos
control
group
p
applic
glycyrrhizin
increas
nse
reduc
gfap
express
astrocyt
order
improv
sciatic
nerv
repair
present
studi
mgkg
dose
glycyrrhizin
shown
promot
function
recoveri
sciatic
nerv
verifi
measur
potenti
amplitud
mncv
mice
dual
stain
affect
spinal
cord
segment
connect
injur
sciatic
nerv
perform
examin
structur
evid
mgkg
dose
glycyrrhizin
elev
number
diamet
myelin
fiber
acceler
nerv
regener
subsequ
gfapand
nsemark
fluoresc
astrocyt
employ
assess
nerv
damageassoci
molecul
upregul
gfap
astrocyt
partial
mark
format
glial
scar
show
astrocyt
interact
fibrou
tissu
reconstruct
glial
layer
around
central
injuri
core
nse
homodim
biomark
matur
neuron
neuroendocrin
cell
highdos
glycyrrhizin
result
increas
nse
reduc
gfap
express
astrocyt
indic
sciatic
nerv
repair
nerv
repair
regener
follow
injuri
involv
complex
biolog
process
includ
inflammatori
respons
adhes
reaction
synergist
effect
extracellular
matrix
regulatori
function
neurotroph
factor
regener
synthesi
releas
neurotransmitt
format
extens
growth
cone
final
neuron
regener
follow
nerv
injuri
local
excess
immun
respons
lead
express
inflammatori
respons
gene
form
local
glial
scar
scar
directli
affect
recoveri
nerv
conduct
reduc
scar
provid
favor
extern
environ
repair
regener
nerv
present
studi
glycyrrhizin
particularli
dose
mgkg
markedli
inhibit
express
protein
mrna
level
throughout
eight
week
experi
downregul
synchron
function
recoveri
sciatic
nerv
structur
myelin
neuron
regener
improv
molecular
marker
consid
apoptosisinduc
receptor
associ
inflammatori
respons
autoimmun
encephalomyel
downregul
may
like
result
reduct
local
inflammatori
respons
lessen
glial
scar
recov
nerv
conduct
function
simultan
downregul
may
attenu
apoptosisinduc
receptor
function
promot
neuron
regener
express
marker
molecul
therefor
sciatic
nerv
regener
associ
downregul
conclus
mgkg
dose
glycyrrhizin
per
day
effect
promot
sciatic
nerv
regener
function
repair
regener
repair
associ
downregul
